Generation of induced pluripotent stem cell line (XDCMHi001-A) from an Ankylosing spondylitis patient with JAK2 mutation

Stem Cell Res. 2020 May:45:101788. doi: 10.1016/j.scr.2020.101788. Epub 2020 Apr 20.

Abstract

Heredity is the major factor contributing to the susceptibility to ankylosing spondylitis(AS). Janus kinase 2 (JAK2) has been associated with AS. Urine-derived cells from an AS patient with JAK2 mutation were used to generate induced pluripotent stem cells (iPSCs) with five episomal iPSC reprogramming vectors (pCXLE-hOCT3/4-shp53-F, pCXLE-hSK, pCXLE-hUL, pCXLE-EGFP and pCXWB-EBNA1). The iPSCs were pluripotent and will be valuable for research on the role and mechanism of JAK2 in the pathogenesis of AS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cellular Reprogramming
  • Humans
  • Induced Pluripotent Stem Cells*
  • Janus Kinase 2 / genetics
  • Mutation
  • Plasmids
  • Spondylitis, Ankylosing* / genetics

Substances

  • JAK2 protein, human
  • Janus Kinase 2